Syvazul BTV
Bluetongue virus vaccine (inactivated) (multistrain: 1-2 strains out of a set of 3)
Table of contents
Overview
Syvazul BTV is a vaccine used in sheep and cattle to protect them against bluetongue disease, an infection caused by the bluetongue virus which is transmitted by midges.
The vaccine contains inactivated (killed) bluetongue viruses. The variety (serotype) of the virus in the vaccine is selected depending on which serotypes are circulating and causing disease at the time of manufacture, so it may contain serotype 1, 4 or 8 or a combination of any two of these.
Authorisation details
Product details | |
---|---|
Name |
Syvazul BTV
|
Agency product number |
EMEA/V/C/004611
|
Active substance |
|
International non-proprietary name (INN) or common name |
Bluetongue virus vaccine (inactivated) (multistrain: 1-2 strains out of a set of 3)
|
Species |
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QI04AA02
|
Publication details | |
---|---|
Marketing-authorisation holder |
LABORATORIOS SYVA, S.A.U.
|
Revision |
3
|
Date of issue of marketing authorisation valid throughout the European Union |
09/01/2019
|
Contact address |
Avda. Parroco Pablo Diez 49-57 |
Product information
20/01/2022 Syvazul BTV - EMEA/V/C/004611 - IAIN/0004
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Therapeutic indication
For active immunisation of sheep to prevent viraemia and reduce clinical signs and lesions caused by bluetongue virus serotypes 1 and/or 8 and/or to reduce viraemia* and clinical signs and lesions caused by bluetongue virus serotype 4
For active immunisation of cattle to prevent viraemia caused by bluetongue virus serotypes 1 and/or 8 and/or to reduce viraemia* caused by bluetongue virus serotype 4.